FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Tirzepatide Injection
Status: Currently in Shortage
»Date first posted: 12/15/2022
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Eli Lilly and Company (Reverified 03/22/2023)

Company Contact Information:
800-545-5979

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
5mg/0.5mL (NDC 0002-1495-80)	Available		Demand increase for the drug
10mg/0.5mL (NDC 0002-1471-80)	Available		Demand increase for the drug
2.5mg/0.5mL (NDC 0002-1506-80)	Available		Demand increase for the drug
7.5mg/0.5mL (NDC 0002-1484-80)	Available		Demand increase for the drug
12.5mg/0.5mL (NDC 0002-1460-80)	Available		Demand increase for the drug
15mg/0.5mL (NDC 0002-1457-80)	Available		Demand increase for the drug